Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion

Authors: Chaganty, Bharat K.R., Qiu, Songbo, Gest, Anneliese, Lu, Yang, Ivan, Cristina, Calin, George A., Weiner, Louis M., Fan, Zhen

Source: In Cancer Letters 28 August 2018 430:47-56

Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab

Authors: Luo, Jingtao, Hong, Yun, Lu, Yang, Qiu, Songbo, Chaganty, Bharat K.R., Zhang, Lun, Wang, Xudong, Li, Qiang, Fan, Zhen

Source: In Cancer Letters 1 January 2017 384:39-49

Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge

Authors: Chaganty, Bharat K.R., Murthy, Ashlesh K., Evani, Shankar J., Li, Weidang, Guentzel, M. Neal, Chambers, James P., Zhong, Guangming, Arulanandam, Bernard P.

Source: In Vaccine 2010 28(11):2323-2329

A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.

Authors: Murthy, Ashlesh K.¹, Chaganty, Bharat K.R.¹, Weidang Li¹, Guentzel, M. Neal¹, Chambers, James P.¹, Seshu, J.¹, Guangming Zhong², Arulanandam, Bernard P.¹ bernard.arulanandam@utsa.edu

Source: FEMS Immunology & Medical Microbiology. Mar2009, Vol. 55 Issue 2, p271-279. 9p. 1 Color Photograph, 6 Graphs.

Subject Terms: *IMMUNOGLOBULINS, *IMMUNITY, *VACCINATION, *IMMUNIZATION, *CHLAMYDIA infections, *PATHOLOGY, *MEDICAL research, *B cells